Nan Fung Group Holdings’s BeOne Medicines Ltd ONC Stock Holding History

Nan Fung Group Holdings’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.48M	Hold	15,722	–	–	3.41%	7
2026 Q1	$4.67M	Hold	15,722	–	–	3.85%	6
2025 Q4	$4.78M	Hold	15,722	–	–	4.28%	8
2025 Q3	$5.36M	Hold	15,722	–	–	8.99%	3
2025 Q2	$3.81M	Hold	15,722	–	–	6%	5
2025 Q1	$4.28M	Sell	15,722 -4,275	-21%	-$999K	3.49%	11
2024 Q4	$3.69M	Sell	19,997 -3,025	-13%	-$618K	3.16%	14
2024 Q3	$5.17M	Hold	23,022	–	–	4.45%	8
2024 Q2	$3.28M	Hold	23,022	–	–	3.5%	12
2024 Q1	$3.6M	Buy	23,022 +11,000	+91%	+$1.77M	3.34%	11
2023 Q4	$2.17M	Hold	12,022	–	–	1.35%	13
2023 Q3	$2.16M	Hold	12,022	–	–	1.75%	12
2023 Q2	$2.14M	Hold	12,022	–	–	1.37%	13
2023 Q1	$2.59M	Hold	12,022	–	–	1.76%	13
2022 Q4	$2.64M	Hold	12,022	–	–	1.82%	12
2022 Q3	$1.62M	Hold	12,022	–	–	1.03%	17
2022 Q2	$1.95M	Hold	12,022	–	–	1.34%	16
2022 Q1	$2.27M	Buy	12,022 +817	+7%	+$174K	1.08%	14
2021 Q4	$3.04M	Buy	+11,205	New	+$3.78M	0.9%	16

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nan Fung Group Holdings's ONC Position: Q2 2026 in Review

Nan Fung Group Holdings held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 15,722 shares worth $4.48M. The position accounts for 3.41% of the portfolio, ranked #7.

Nan Fung Group Holdings first reported a position in ONC in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.36M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Nan Fung Group Holdings held 15,722 shares of BeOne Medicines Ltd worth $4.48M as of Q2 2026.
Nan Fung Group Holdings left its BeOne Medicines Ltd share count unchanged in Q2 2026.
BeOne Medicines Ltd made up 3.41% of Nan Fung Group Holdings's portfolio in Q2 2026, its #7 holding.
Nan Fung Group Holdings first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 19 quarters since.
Nan Fung Group Holdings's BeOne Medicines Ltd position peaked at $5.36M in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.